Post by TPost by Citizen Winston SmithPost by Citizen Winston SmithPost by TThe Amish evidence is really, really damning.
And therefore dismissed and ignored.
This is a case of follow the money. Although not the
narrative, the Democratic part and the RINO's only serve
the interests of the rich. And both get their palms
waxed by Big Pharma. Well, more then their palms,
their entire bodies. Think wax sculptures.
I do hold hope of RFK really digging in to them,
https://www.newsmax.com/politics/rfk-trump-hhs/2024/11/08/id/1187353/
+1
https://www.newsweek.com/rfk-jr-fda-departments-trump-presidency-1981671
Robert F. Kennedy Jr. has said he will clear out "entire departments" of
the U.S. Food and Drug Administration (FDA) if given a place in Donald
Trump's administration, as the former president has repeatedly promised.
"In some categories, there are entire departments, like the nutrition
department at the FDA that are – that have to go, that are not doing
their job, they're not protecting our kids," Kennedy said during a
Wednesday morning interview on MSNBC.
https://www.pharmavoice.com/news/rfk-jr-trump-administration-pharma-fda/732326/
Like many political leaders on both sides of the aisle, Kennedy has
signaled his support for capping drug costs.
“Legislators should cap drug prices so that companies can’t charge
Americans substantially more than Europeans pay,” Kennedy wrote in a
Wall Street Journal op-ed in September.
In the public health sphere, Kennedy is perhaps most well known for his
anti-vaccine conspiracy theories. In particular, Kennedy wants to use
federal health data to prove vaccines are unsafe, which could get them
pulled from the market, Trump transition team officials said in October.
However, Kennedy said this week he “won’t take away anyone’s vaccines”
and instead promoted “choice.”
Kennedy also wants to upend funding for the National Institutes of
Health and has touted a plan to “devote half of research budgets …
toward preventive, alternative and holistic approaches to health,” he
wrote in September.
Kennedy’s distrust of the pharma industry is also underlined in his aim
to revisit direct-to-consumer pharmaceutical ad guidelines.
In an op-ed, Kennedy suggested news channels may be influenced by drug
ad revenue in their health news coverage. Total ad spending among the
top 10 pharma companies was nearly $3 billion last year.
Kennedy wants to take up the mantle of battling chronic disease under
Trump’s directive with the goal to make substantial improvements among
children within two years.
Trump has questioned whether “the overprescription of certain
medications” is to blame obesity in the U.S. AndKennedy has postulated
that the pharma and healthcare industries profit from chronically sick
children.